Evaluation of the Digene Hybrid Capture II assay with the Rapid Capture System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Journal of Clinical Microbiology

Volumn 40, Issue 10, 2002, Pages 3558-3564

  Van Der Pol, B ^a   Williams, J A ^a   Smith, N J ^a   Batteiger, B E ^a   Cullen, A P ^a   Erdman, H ^a   Edens, T ^a   Davis, K ^a   Salim Hammad, H ^a   Chou, V W ^a   Scearce, L ^a   Blutman, J ^a   Payne, W J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSAY; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; DIGENE HYBRID CAPTURE ASSAY; DISEASE CONTROL; EVALUATION; GONORRHEA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; NEISSERIA GONORRHOEAE; NEWBORN INFECTION; PRIORITY JOURNAL; SCREENING; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CYTOLOGY;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; NEISSERIA GONORRHOEAE; POLYMERASE CHAIN REACTION; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; NEISSERIA; NEISSERIA GONORRHOEAE;

EID: 0036790207     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.10.3558-3564.2002     Document Type: Article

References (32)

1. American Social Health Association. 1998. Sexually transmitted diseases in America: how many cases and at what cost? Kaiser Family Foundation, Menlo Park, Calif.
2. Baselski, V. S. 1996. The role of molecular diagnostics in the clinical microbiology laboratory. Clin. Lab. Med. 16:49-60.
3. Battle, T. J., M. R. Golden, K. L. Suchland, J. M. Counts, J. P. Hughes, W. E. Stamm, and K.K. Holmes. 2001. Evaluation of laboratory testing methods for Chlamydia trachomatis infection in the era of nucleic acid amplification. J. Clin. Microbiol. 39:2924-2927.
4. Bignell, C. J. 2001. European guideline for the management of gonorrhoea. Int. J. STD AIDS 12(Suppl. 3):27-29.
5. Burstein, G., M. Snyder, D. Conley, M. Howell, B. Boekeloo, T. Quinn,and J. Zenilman. 2000. Screening females for Chlamydia trachomatis in a large managed care organization (MCO). A new HEDIS measure. J. Pediatr. Adolesc. Gynecol. 13:91.
6. Carroll, K. C., W. E. Adleen, M. Morrison, R. Anderson, D. Lee, and S. Mottice. 1998. Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J. Clin. Microbiol. 36:1630-1633.
7. Cates, W., Jr., and The American Social Health Association Panel. 1999. Estimates of the incidence and prevalence of sexually transmitted disease in the United States. Sex. Transm. Dis. 26(Suppl.):S2-S7.
8. Centers for Disease Control and Prevention. 1997. Chlamydia trachomatis genital infections - United States, 1995. Morb. Mortal. Wkly. Rep. 46:193-198.
9. Centers for Disease Control and Prevention. 1998. 1998 guidelines for treatment of sexually transmitted diseases. Morb. Mortal. Wkly. Rep. 47(RR-1):1-116.
10. Darwin, L. H., A. P. Cullen, P. M. Arthur, C. D. Long, K. R. Smith, J. L. Girdner, E. W. Hook III, T. C. Quin, and A. T. Lorincz. 2002. Comparison of Digene Hybrid Capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J. Clin. Microbiol. 40:641-644.
11. Gerbase, A. C., J. T. Rowley, D. H. L. Heymann, S. F. B. Berkley, and P. Piot 1998. Global prevalence and incidence estimates of selected curable STDs. Sex. Transm. Infect. 74(Suppl. 1):512-517.
12. Girdner, J. L., A. P. Cullen, T. G. Salama, L. He, A. Lorincz, and T. C. Quinn. 1999. Evaluation of the Digene Hybrid Capture II CT-ID test for detection of Chlamydia trachomatis in endocervical specimens. J. Clin. Microbiol. 37:1579-1581.
13. Hadgu, A. 1997. Bias in the evaluation of DNA-amplification tests for detecting Chlamydia trachomatis. Statist. Med. 16:1391-1399.
14. Howell, M. R., T. C. Quinn, W. Brathwaite, and C. A. Gaydos. 1998. Screening women for Chlamydia trachomatis in family planning clinics. Sex. Transm. Dis. 25:108-116.
15. Jones, R. B., B. Van Der Pol, and B. P. Katz. 1989. Effect of differences in specimen processing and passage technique on recovery of Chlamydia trachomatis. J. Clin. Microbiol. 27:894-898.
16. Klapper, P. E., D. L. Jungkind, T. Fenner, R. Antinozzi, J. Schirm, and C. Blanckmeister. 1998. Multicenter international work flow study of an automated polymerase chain reaction instrument. Clin. Chem. 44:1737-1739.
17. Laughon, B. E., J. M. Ehret, T. T. Tanino, B. Van Der Pol, H. H. Handsfield, R. B. Jones, F. N. Judson, and E. W. Hook III. 1987. Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J. Clin. Microbiol. 25:2388-2390.
18. Livengood, C. H., III, and J. W. Wrenn. 2001. Evaluation of COBAS AMPLICOR (Roche): accuracy in detection of Chlamydia trachomatis and Neisseria gonorrhoeae by coamplification of endocervical specimens. J. Clin. Microbiol. 39:2928-2932.
19. Mangione-Smith, R., J. O'Leary, and E. A. McGlynn. 1999. Health and cost-benefits of Chlamydia screening in young women. Sex. Transm. Dis. 26:309-316.
20. Mardh, P. A. 2000. Chlamydia screening-yes, but of whom, when, by whom, and with what? Ann. N. Y. Acad. Sci. 900:286-292.
21. Marrazzo, J. M., C. L. Celum, S. D. Hillis, D. Fine, S. Delisle, and H. H. Handsfield. 1997. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Sex. Transm. Dis. 24:131-141.
22. Martin, D. H., C. Cammarata, B. Van Der Pol, R. B. Jones, T. C. Quinn, C. A. Gaydos, K. Crotchfelt, J. Schachter, J. Moncada, D. Jungkind, B. Turner, and C. Peyton 2000. Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J. Clin. Microbiol. 38:3544-3549.
23. Oh, M., D. Grimley, and G. Heudebert. 2000. Population-level intervention to promote chlamydia screening. Moving toward implementation of chlamydia hedis 2000 measure. J. Pediatr. Adolesc. Gynecol. 13:95.
24. Rein, D. B., W. J. Kassler, K. L. Irwin, and L. Rabiee. 2000. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet. Gynecol. 95:397-402.
25. Schachter, J., E. W. Hook III, W. M. McCormack, T. C. Quinn, M. Chernesky, S. Chong, J. I. Girdner, P. B. Dixon, L. DeMeo, E. Williams, A. Cullen, and A. Lorincz. 1999. Ability of the Digene Hybrid Capture II test to identify Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J. Clin. Microbiol. 37:3668-3671.
26. Silman, A. J. 1995. Analysis of reproducibility 9.2a, p. 77-78. In Epidemiological studies: a practical guide. Cambridge University Press, New York, N.Y.
27. Stary, A. 2001. European guideline for the management of chlamydial infection. Int. J. STD AIDS 12(Suppl. 3):30-33.
28. Van Der Pol, B., D. V. Ferrero, L. Buck-Barrington, E. Hook III, C. Lenderman, T. Quinn, C. A. Gaydos, J. Lovchik, J. Schachter, J. Moncada, G. Hall, M. J. Tuohy, and R. B. Jones. 2001. Multicenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J. Clin. Microbiol. 39:1008-1016.
29. Van Der Pol, B., T. C. Quinn, C. A. Gaydos, K. Crotchfelt, J. Schachter, J. Moncada, D. Jungkind, D. H. Martin, B. Turner, C. Peyton, and R. B. Jones. 2000. Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J. Clin. Microbiol. 38:1105-1112.
30. Van Dyck, E., M. Ieven, S. Pattyn, L. Van Damme, and M. Laga. 2001. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J. Clin. Microbiol. 39:1751-1756.
31. van Valkengoed, I. G., M. J. Postma, S. A. Morre, A. J. van den Brule, C. J. Meijer, L. M. Bouter, and A. J. Boeke. 1997. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. Sex. Transm. Infect. 77:276-282.
32. Washington, A. E., and P. Katz. 1991. Cost of and payment source for pelvic inflammatory disease: Trends and projections, 1983 through 2000. JAMA 266:2565-2569.